{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T21:03:55Z","timestamp":1744059835485},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1989,2,1]],"date-time":"1989-02-01T00:00:00Z","timestamp":602294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[1989,2]]},"DOI":"10.1007\/bf00595896","type":"journal-article","created":{"date-parts":[[2004,11,24]],"date-time":"2004-11-24T06:35:22Z","timestamp":1101278122000},"page":"401-402","source":"Crossref","is-referenced-by-count":9,"title":["Treatment of fever and neutropenia with antibiotics versus antibiotics plus intravenous gammaglobulin in childhood leukemia"],"prefix":"10.1007","volume":"148","author":[{"given":"T.","family":"Sumer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Abumelha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Al-Mulhim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Al-Fadil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000466897","volume":"37","author":"WJ Alexander","year":"1979","unstructured":"Alexander WJ, Deitcher H, Kornhuber B, Luiken GA, Ochs HD, Pirofsky B (1979) Which is factual basis in theory and clinical practice for the use of intravenous gammaglobulin in the treatment of severe bacterial infections? Vox Sang 37:116?128","journal-title":"Vox Sang"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0171-2985(81)80092-7","volume":"159","author":"W Ax","year":"1981","unstructured":"Ax W, Kanzy EJ, Seiler FR (1981) In-vivo phagocytosis:enhancement of bacterial clearence by native and enzyme treated immunoglobulins. Immunobiology 159:349?365","journal-title":"Immunobiology"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/07357908509039797","volume":"3","author":"JB Bussel","year":"1985","unstructured":"Bussel JB, Cunningham-Rundles C (1985) Intravenous use of gammaglobulin: humoral immunodeficiency, immune thrombocytopenic purpura and newer indications. Cancer Invest 3:361?366","journal-title":"Cancer Invest"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.7326\/0003-4819-101-4-435","volume":"101","author":"C Cunningham-Rundles","year":"1984","unstructured":"Cunningham-Rundles C, Siegal FP, Smithwick EM (1984) Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease. Ann Intern Med 101:435?439","journal-title":"Ann Intern Med"},{"key":"CR5","first-page":"2559","volume":"38","author":"S Ikeda","year":"1985","unstructured":"Ikeda S, Ichimaru M (1985) The use of SM-4300 against the severe infections complicated with hematological diseases. Jpn J Antibiot 38:2559?2563","journal-title":"Jpn J Antibiot"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/infdis\/152.4.695","volume":"152","author":"RF Jacobs","year":"1985","unstructured":"Jacobs RF, Kiel DP, Sanders ML, Steel RW (1985) Phagocytosis of type III groups B streptococci by neonatal monocytes: enhancement by fibrocetin and gammaglobulin. J Infect Dis 152:695?700","journal-title":"J Infect Dis"},{"key":"CR7","first-page":"107","volume-title":"Immunoglobulins; characteristics and uses of intravenous preparations","author":"B Kornhuber","year":"1979","unstructured":"Kornhuber B (1979) Administration of intravenous immunoglobulin to children with malignant diseases. In: Alving BM, Finlaysen JS (eds) Immunoglobulins; characteristics and uses of intravenous preparations. US Department of Health and Human Services, Bethesda, Md., pp 107?109"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0308-2261(18)30033-X","volume":"13","author":"OBL McClelland","year":"1984","unstructured":"McClelland OBL, Yap PL (1984) Clinical use of immunoglobulins. Clin Haematol 13:39?74","journal-title":"Clin Haematol"},{"key":"CR9","first-page":"2565","volume":"38","author":"I Nagamatsu","year":"1985","unstructured":"Nagamatsu I, Sato Y, Miyanoshita A (1985) Clinical studies on SM-4300 in children. Jpn J Antibiot 38:2565?2570","journal-title":"Jpn J Antibiot"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0002-9343(84)90320-6","volume":"76","author":"B Pirofsky","year":"1984","unstructured":"Pirofsky B, Montanaro A (1984) Prolonged interval high-dose intravenous immunoglobulin in patients with primary immunodeficiency states. Am J Med 76:67?72","journal-title":"Am J Med"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0002-9343(84)90737-X","volume":"76","author":"HS Polmar","year":"1984","unstructured":"Polmar HS, Sorenson RU (1984) Efficacy and safety of high dose intravenous immune globulin therapy for antibody deficient syndromes. Am J Med 76:8","journal-title":"Am J Med"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.7164\/antibiotics.38.249","volume":"38","author":"N Suzuki","year":"1985","unstructured":"Suzuki N, Watanabe A (1985) Clinical evaluation on combination therapy antibiotics and gamma globulin preparation (SM-4300) in the field of pediatrics. Jpn J Antibiot 38:1571?1576","journal-title":"Jpn J Antibiot"},{"key":"CR13","first-page":"2594","volume":"38","author":"T Takashima","year":"1985","unstructured":"Takashima T, Tabuki K, Nishimura T, Tagaki M (1985) Laboratory and clinical studies on SM-4300 in pediatric field. Jpn J Antibiot 38: 2594?2602","journal-title":"Jpn J Antibiot"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00595896.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00595896\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00595896","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T15:22:07Z","timestamp":1624980127000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00595896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,2]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1989,2]]}},"alternative-id":["BF00595896"],"URL":"https:\/\/doi.org\/10.1007\/bf00595896","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,2]]}}}